Alom Firoj, Miyakawa Masumi, Matsuyama Hayato, Nagano Hiroshi, Tanahashi Yasuyuki, Unno Toshihiro
Department of Pathogenetic Veterinary Science, United Graduate School of Veterinary Science, Gifu University, 1-1 Yanagido, Gifu 501-1193, Japan.
Laboratory of Veterinary Pharmacology, Department of Veterinary Medicine, Faculty of Applied Biological Science, Gifu University, 1-1 Yanagido, Gifu 501-1193, Japan.
J Vet Med Sci. 2018 Sep 13;80(9):1407-1415. doi: 10.1292/jvms.18-0197. Epub 2018 Jul 5.
ML204, a potent transient receptor potential canonical 4 (TRPC4) channel blocker, is often used to elucidate the involvement of TRPC4 channels in receptor-operated signaling processes in visceral smooth muscles. In the present study, we investigated the possible antagonistic actions of ML204 on M and M muscarinic receptors, which mediate contractions in mouse ileal and detrusor smooth muscles. In ileal and detrusor smooth muscle preparations, ML204 (3 or 10 µM) significantly inhibited electrical field stimulation (EFS)-evoked cholinergic contractions. However, it did not significantly inhibit high K-induced and EFS-evoked non-cholinergic contractions in the ileal preparations. When the muscarinic agonist, carbachol was cumulatively applied, ML204 (1, 3 and 10 µM) caused a rightward parallel shift of the concentration-response curves of carbachol. Additionally, ML204 (1, 3 and 10 µM) inhibited carbachol-induced negative chronotropic response in atrial preparations, which is mediated by M muscarinic receptors. Furthermore, ML204 significantly inhibited the contractions evoked by carbachol-induced intracellular Ca release, which is mediated by M muscarinic receptors. These results suggested that ML204 might exhibit antagonistic actions on M and M muscarinic receptors; in addition, the inhibitory effects of ML204 against EFS-induced cholinergic contractions might be attributed to this receptor antagonism rather than inhibition of TRPC4 channel activity. Therefore, these effects should be considered when ML204 is used as a TRPC4 channel blocker.
ML204是一种有效的瞬时受体电位阳离子通道蛋白4(TRPC4)通道阻滞剂,常用于阐明TRPC4通道在内脏平滑肌受体介导的信号传导过程中的作用。在本研究中,我们研究了ML204对M和M毒蕈碱受体可能的拮抗作用,这两种受体介导小鼠回肠和逼尿肌平滑肌的收缩。在回肠和逼尿肌平滑肌标本中,ML204(3或10 μM)显著抑制电场刺激(EFS)诱发的胆碱能收缩。然而,它并没有显著抑制回肠标本中高钾诱导的和EFS诱发的非胆碱能收缩。当累积应用毒蕈碱激动剂卡巴胆碱时,ML204(1、3和10 μM)使卡巴胆碱的浓度-反应曲线向右平行移动。此外,ML204(1、3和10 μM)抑制了心房标本中由M毒蕈碱受体介导的卡巴胆碱诱导的负性变时反应。此外,ML204显著抑制了由M毒蕈碱受体介导的卡巴胆碱诱导的细胞内钙释放所诱发的收缩。这些结果表明,ML204可能对M和M毒蕈碱受体表现出拮抗作用;此外,ML204对EFS诱导的胆碱能收缩的抑制作用可能归因于这种受体拮抗作用,而不是对TRPC4通道活性的抑制。因此,当将ML204用作TRPC4通道阻滞剂时,应考虑这些作用。